Sign in

CIK 0001427570

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

Vyome Holdings, Inc

Sign in to watch
Ticker
HIND
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 949-429-6680
Business address
1001 CALLE AMANECER, SAN CLEMENTE, CA, 92673
Former names
ReShape Lifesciences Inc., OBALON THERAPEUTICS INC
  1. 3 Insider Initial Statement of Ownership
  2. 4 Open-market buy VP Research and Development bought 5,000 shares at $3.96 ($19,778)
  3. 4 Open-market buy Chief Financial Officer bought 30,000 shares at an average $4.04 ($121,330)
  4. 4 Option exercise VP Research and Development acquired 13,926 shares (option exercise)
  5. 4 Option exercise VP of Reg. and Clin. Affairs acquired 6,650 shares (option exercise)
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Grant or award Chief Technology Officer acquired 65,000 shares (grant or award)
  15. 4 Grant or award VP of Reg. and Clin. Affairs acquired 60,000 shares (grant or award)
  16. 4 Grant or award VP of Finance acquired 502 shares (grant or award)
  17. 4 Grant or award President & CEO acquired 808 shares (grant or award)
  18. 4 Grant or award VP of Operations acquired 942 shares (grant or award)
  19. 4 Grant or award VP Research and Development acquired 1,743 shares (grant or award)
  20. 4 Grant or award Chief Technology Officer acquired 1,860 shares (grant or award)

Page 9 of 13 · 243 filings